Lenvatinib is used in the treatment of thyroid cancer.
How Lenvatinib works Lenvatinib is a tyrosine kinase inhibitor. It functions by blocking the supply of oxygen and nutrients to cancer cells, resulting in their growth cessation.
Common side effects of Lenvatinib include diarrhea, high blood pressure, protein in urine, anemia (low number of red blood cells), heart failure, liver toxicity, decreased calcium levels in the blood, thyroid disorders, and renal failure.